What's in German CLL Study Group's pipeline?

German CLL Study Group has 9 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 3 in Phase 2, 3 in Phase 1.

Which companies overlap with German CLL Study Group's portfolio?

Top competitors by shared drug class: Bayer, Novartis, National Cancer Institute (NCI), Addpharma Inc., Ahn-Gook Pharmaceuticals Co.,Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/german-cll-study-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

German CLL Study Group — Portfolio Competitive Intelligence Brief

German CLL Study Group pipeline: 0 marketed, 0 filed, 3 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 3 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Fludarabine plus Cyclophosphamide	Fludarabine plus Cyclophosphamide	phase 3	Chemotherapy combination (purine analog + alkylating agent)		Oncology
Fludarabine plus Darbopoetin	Fludarabine plus Darbopoetin	phase 3	Combination chemotherapy with erythropoiesis-stimulating agent	DNA synthesis pathway (fludarabine); erythropoietin receptor (darbopoetin)	Oncology
Fludarabine mono	Fludarabine mono	phase 3	Purine analog antimetabolite	Ribonucleotide reductase; DNA polymerase	Oncology

Therapeutic area mix

Oncology · 6

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 2 shared drug classes
Novartis · 2 shared drug classes
National Cancer Institute (NCI) · 2 shared drug classes
Addpharma Inc. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Alexion Pharmaceuticals, Inc. · 1 shared drug class
AgeneBio · 1 shared drug class
Amgen · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for German CLL Study Group:

Cite this brief

Drug Landscape (2026). German CLL Study Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/german-cll-study-group. Accessed 2026-05-13.